Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: March 23, 2023

Details for New Drug Application (NDA): 012179

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 012179 describes VOSOL, which is a drug marketed by Akorn and is included in two NDAs. It is available from three suppliers. Additional details are available on the VOSOL profile page.

The generic ingredient in VOSOL is acetic acid, glacial; hydrocortisone. There are thirty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the acetic acid, glacial; hydrocortisone profile page.
Summary for 012179
Ingredient:acetic acid, glacial
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 012179
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VOSOL acetic acid, glacial SOLUTION/DROPS;OTIC 012179 NDA A-S Medication Solutions 50090-0351 50090-0351-0 1 BOTTLE in 1 BOX (50090-0351-0) / 15 mL in 1 BOTTLE
VOSOL acetic acid, glacial SOLUTION/DROPS;OTIC 012179 NDA Akorn 50383-889 50383-889-15 1 BOTTLE in 1 BOX (50383-889-15) / 15 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OTICStrength2%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.